A double blind, randomized, placebo-controlled, parallel group study of Sativex oromucosal spray (Sativex®; Nabiximols) as adjunctivetherapy in relieving uncontrolled persistent chronic pain in patients with advanced cancer, who experience inadequate analgesia during optimized chronic opioid therapy; Three hundred and eighty patients (190 per treatment arm (Sativex or placebo)

A treatment for women with HER-2 overexpressing positive breast cancer.

To evaluate the safety of long term Sativex therapy when used as an adjunctive (not breakthrough) measure in patients with advanced cancer

This is a clinical trial comparing adjuvant clodronate therapy vs placebo in early stage breast cancer patients receiving chemotherapy and/or hormonal therapy.

Cancer pain management for breast/prostate cancer

Cancer pain management

Therapy for premenopausal women and early postmenopausal women who have had surgery for high risk breast cancer.